Panbela Therapeutics PER
¿Qué es el PER de Panbela Therapeutics?
El PER de Panbela Therapeutics Inc. es 0.00
¿Cuál es la definición de PER?
La relación precio/ganancias es la relación entre el precio de las acciones de una compañía y las ganancias por acción de la compañía calculadas en los últimos doce meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
PER de compañías en Sector Health Care en NASDAQ en comparadas con Panbela Therapeutics
¿Qué hace Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas con per similar a Panbela Therapeutics
- Rurelec PLC tiene PER de 0.00
- Tomizone tiene PER de 0.00
- Nanogate AG tiene PER de 0.00
- SEL Manufacturing tiene PER de 0.00
- China Zhong Qi Hldgs tiene PER de 0.00
- MedSmart tiene PER de 0.00
- Panbela Therapeutics tiene PER de 0.00
- Epic tiene PER de 0.00
- 2574 tiene PER de 0.00
- GERRY WEBER International AG tiene PER de 0.00
- Houston Nat Res tiene PER de 0.00
- CTPartners Executive Search tiene PER de 0.00
- Crown ElectroKinetics tiene PER de 0.00